10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-031144`
Period End Date	20140331
Filing Date	20140515
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	bpth-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 43 Cash Flow Statement 69

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$16.82M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$534.05K	USD	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Cash	`Cash`	$288.71K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$51.36K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$249.06K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$64.12K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$157.46K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$17.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.67M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	489,501.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.24M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	84.24M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.24M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	84.24M	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.09M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.13M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.37M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.41M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$18.60M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.08M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$76.11K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$238.03K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$1.00K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$66.74K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$78.88K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$52.05K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$52.05K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$294.90K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$419.96K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$419.96K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$294.90K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,237,872 and 84,237,872 shares issued and outstanding as of 3/31/14 and 12/31/13, respectively	`CommonStockValue`	$89.24K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,237,872 and 84,237,872 shares issued and outstanding as of 3/31/14 and 12/31/13, respectively	`CommonStockValue`	$84.24K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$33.99M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$20.10M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$15.40M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$15.90M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$18.18M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.78M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$18.60M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.08M	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$1.18M	USD	28 Qtrs
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	28 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.95M	USD	28 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$401.10K	USD	1 Quarter
Technology impairment charge	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$107.64K	USD	1 Quarter
Technology impairment charge	`OtherAssetImpairmentCharges`	$345.00K	USD	Point-in-time
Technology impairment charge	`OtherAssetImpairmentCharges`	$690.00K	USD	28 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$9.07M	USD	28 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$380.85K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$239.81K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$16.23M	USD	28 Qtrs
Total operating expense	`OperatingExpenses`	$655.91K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$510.21K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-16.23M	USD	28 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-510.21K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-655.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$124.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$86.70K	USD	28 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.57K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$244.48K	USD	28 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$5.22K	USD	28 Qtrs
Other expense	`OtherNonoperatingExpense`	$239.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$216.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$-92.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$325.96K	USD	28 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.33K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-15.90M	USD	28 Qtrs
Net Loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	28 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62.22M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	51.27M	shares	28 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	1 Quarter

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.90M	USD	28 Qtrs
Net loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$1.18M	USD	28 Qtrs
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Point-in-time
Technology impairment	`OtherAssetImpairmentCharges`	$690.00K	USD	28 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$795.00K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$318.50K	USD	28 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Stock options and warrants	`ShareBasedCompensation`	$3.80M	USD	28 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$16.02K	USD	1 Quarter
Stock options and warrants	`ShareBasedCompensation`	$86.28K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-99.00K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$197.69K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$249.06K	USD	28 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$157.46K	USD	28 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$93.35K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$11.35K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$125.06K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$419.96K	USD	28 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-38.83K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-551.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-544.42K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.90M	USD	28 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	-	USD	1 Quarter
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$884.71K	USD	28 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-884.71K	USD	28 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	28 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	28 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	1 Quarter
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$305.67K	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$27.18M	USD	28 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.81M	USD	1 Quarter
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.60M	USD	28 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.81M	USD	1 Quarter
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$305.67K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$16.82M	USD	28 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$13.27M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-245.34K	USD	1 Quarter
Cash, beginning of period	`Cash`	$16.82M	USD	Point-in-time
Cash, beginning of period	`Cash`	$534.05K	USD	Point-in-time
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$288.71K	USD	Point-in-time
Cash, beginning of period	`Cash`	-	USD	Point-in-time
Cash, end of period	`Cash`	$16.82M	USD	Point-in-time
Cash, end of period	`Cash`	$534.05K	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$288.71K	USD	Point-in-time
Cash, end of period	`Cash`	-	USD	Point-in-time
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	$445.00	USD	28 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	28 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	1 Quarter
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	28 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.